Chemical Compound

(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

CAS Registry Number 162635-04-3
(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate 结构式
Primary record

(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

库存
1,462 克
纯度
99.3 %
CAS
162635-04-3

化合物标识与属性

CAS
162635-04-3
PubChem CID
6918289
SMILES
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC
Canonical SMILES
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C

名称与同义词

  • Temsirolimus
  • Torisel
  • CCI-779
  • temsirolimusum
  • Temserolimus
  • Temsorolimus
  • Temsirolimus?
  • Temsirolimus Injection
  • Temsirolimus [USAN]
  • 162635-04-3
  • Temsirolimus - Torisel
  • RefChem:56883
  • Temsirolimus (>80%)
  • Cci 779
  • 624KN6GM2T
  • TEMSIROLIMUS [MI]
  • Temsirolimus(CCI-779)
  • DTXSID2040945
  • TEMSIROLIMUS [INN]
  • TEMSIROLIMUS [JAN]
  • TEMSIROLIMUS [VANDF]
  • UNII-624KN6GM2T
  • MFCD00934421
  • CHEMBL1201182
  • DTXCID0020945
  • TEMSIROLIMUS [MART.]
  • TEMSIROLIMUS [WHO-DD]
  • WAY-CCI 779
  • C56H87NO16
  • GTPL5892
  • orb1306354
  • TEMSIROLIMUS [EMA EPAR]
  • HSDB 7931
  • L01XE09
  • Temsirolimus, >=98% (HPLC)
  • CBPNZQVSJQDFBE-FUXHJELOSA-N
  • GLXC-90175
  • TEMSIROLIMUS [ORANGE BOOK]
  • AOB87306
  • Temsirolimus [USAN:INN:BAN:JAN]
  • Tox21_112515
  • BDBM50343413
  • NCGC00167518-01
  • s1044
  • AKOS025142069
  • AM84554
  • CCG-264790
  • CS-0129
  • FR61494
  • NSC 683864
  • NSC-683864
  • RL02091
  • SDCCGSBI-0654330.P001
  • NCGC00167518-02
  • NCGC00167518-05
  • NCGC00167518-09
  • Rapamycin 42-(2,2-bis(hydroxymethyl)propionate)
  • HY-50910
  • RT-015903
  • Temsirolimus (CCI-779, NSC 683864)
  • A8314
  • CAS-162635-04-3
  • T3574
  • AB01274736-01
  • AB01274736_02
  • 635T043
  • Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)
  • SR-01000898799
  • Q7699074
  • SR-01000898799-3
  • BRD-K08177763-001-02-6
  • Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]
  • 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin
  • Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate
  • (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
  • ((1R,2R,4S)-4-((2R)-2-((1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraen-12-yl)propyl)-2-methoxycyclohexyl) 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
  • (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
  • (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 4'-(2,2-bis(hydroxymethyl)propionate)
  • [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxy-cyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methyl-propanoate
  • [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
  • [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoateEE
  • A4I
  • Rapamycin, 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate]; 40-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin; CCI 779; Temsirolimus; Temsorolimus; Torisel; WAY-CCI 779